123 related articles for article (PubMed ID: 19065667)
1. Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase.
Ye L; Gho WM; Chan FL; Chen S; Leung LK
Int J Cancer; 2009 Mar; 124(5):1028-36. PubMed ID: 19065667
[TBL] [Abstract][Full Text] [Related]
2. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells.
Wang Y; Lee KW; Chan FL; Chen S; Leung LK
Toxicol Sci; 2006 Jul; 92(1):71-7. PubMed ID: 16611627
[TBL] [Abstract][Full Text] [Related]
3. Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7.
Li F; Ye L; Lin SM; Leung LK
Mol Cell Endocrinol; 2011 Sep; 344(1-2):51-8. PubMed ID: 21741436
[TBL] [Abstract][Full Text] [Related]
4. The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice.
Ye L; Chan FL; Chen S; Leung LK
J Nutr Biochem; 2012 Oct; 23(10):1230-7. PubMed ID: 22209285
[TBL] [Abstract][Full Text] [Related]
5. The licorice flavonoid isoliquiritigenin suppresses phorbol ester-induced cyclooxygenase-2 expression in the non-tumorigenic MCF-10A breast cell line.
Lau GT; Ye L; Leung LK
Planta Med; 2010 May; 76(8):780-5. PubMed ID: 20033868
[TBL] [Abstract][Full Text] [Related]
6. The licorice flavonoid isoliquiritigenin reduces DNA-binding activity of AhR in MCF-7 cells.
Wong TY; Lin SM; Poon CH; Leung LK
Chem Biol Interact; 2014 Sep; 221():70-6. PubMed ID: 25110319
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.
Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687
[TBL] [Abstract][Full Text] [Related]
8. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
10. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.
Kijima I; Phung S; Hur G; Kwok SL; Chen S
Cancer Res; 2006 Jun; 66(11):5960-7. PubMed ID: 16740737
[TBL] [Abstract][Full Text] [Related]
11. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
Ju YH; Doerge DR; Helferich WG
Food Chem Toxicol; 2008 Jan; 46(1):310-20. PubMed ID: 17919800
[TBL] [Abstract][Full Text] [Related]
12. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus).
Chen S; Oh SR; Phung S; Hur G; Ye JJ; Kwok SL; Shrode GE; Belury M; Adams LS; Williams D
Cancer Res; 2006 Dec; 66(24):12026-34. PubMed ID: 17178902
[TBL] [Abstract][Full Text] [Related]
13. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
Belosay A; Brodie AM; Njar VC
Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
[TBL] [Abstract][Full Text] [Related]
14. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
[TBL] [Abstract][Full Text] [Related]
15. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
16. The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer.
Li F; Chow S; Cheung WH; Chan FL; Chen S; Leung LK
J Nutr Biochem; 2013 Jun; 24(6):1112-6. PubMed ID: 23238426
[TBL] [Abstract][Full Text] [Related]
17. A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene.
Yue W; Zhou D; Chen S; Brodie A
Cancer Res; 1994 Oct; 54(19):5092-5. PubMed ID: 7923123
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells.
Kijima I; Ye J; Glackin C; Chen S
Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I; Itoh T; Chen S
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
[TBL] [Abstract][Full Text] [Related]
20. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
